We have updated our Terms of Use.
Please read our new Privacy Statement before continuing.

Botched operation

3 September 2012 By Quentin Webb

Regulators, politicians, your own wary investors: so many people can nix a big deal. Fresenius’s failed $4 bln bid for a rival German health group shows another risk. High approval hurdles can empower an awkward squad with smallish stakes in the target. Glencore must sympathise.

This content is for Subscribers only


Email a friend

Please complete the form below.

Required fields *


(Separate multiple email addresses with commas)